retatrutide phase 2 trial type 2 diabetes weight loss 🚨Breaking: Retatrutide's first 3 T2D data just dropped. ▸ A1C: −2.0% at 40 weeks ▸ Weight: −36.6 lbs (−16.8%) at 12 mg ▸ No plateau — curve still descending ESC 2024: Retatrutide improves lipid

Clin Nutr (2017) 36(6):17079.10.1016/j.clnu.2016.09.028 187 LiuRHongJXuXFengQZhangDGuYet alGut microbiome and serum metabolome alterations in obesity and after weight-loss intervention

Some experienced huge reductions in liver fat, whereas others displayed more modest changes

Speedy delivery

Available from: Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jdar E, Leiter LA et al (2016) Semaglutide and cardiovascular outcomes in patients with type 2 diabetes

Fermentation of Fiber Beneficial gut bacteria break down dietary fiber into short-chain fatty acids (SCFAs), such as butyrate and propionate

When discussed in the media, it has been nicknamed Triple G. By working on three hormones, retatrutide has been demonstrated in clinical trials to help reduce appetite, control blood sugar, and promote fat loss